Zhuhai Rundu Pharmaceutical (002923.SZ): Valsartan potassium raw material obtains CEP certificate.

Zhuhai Rundu Pharmaceutical (002923.SZ) announced that the company has recently received the Certificate of Suitability to Monograph of European Pharmacopoeia (CEP) issued by the European Directorate for the Quality of Medicines (EDQM). Obtaining the CEP certificate signifies recognition of the manufacturing process and quality of the active pharmaceutical ingredient by European standard markets and other markets that accept CEP certificates. This provides the company with a competitive advantage and opportunities to further expand into international markets.